Skip to main content

Table 4 Management of rebleeding in the studied groups

From: Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial

Variables Sclerotherapy group N: 15 (%) Cyanoacrylate group N: 11 (%)
Timing Early rebleeding 5 (33.33%) 3 (27.27%)
Late rebleeding 10 (66.67%) 8 (72.73%)
Clinical presentation Hematemesis 8 (53.33%) 6 (54.55%)
Melena 3 (20%) 3 (27.27%)
Hematemesis and melena 4 (26.67%) 2 (18.18%)
Causes Bleeding from the same site and/or post injection esophageal ulcers 7 (46.67%) 2 (18.18)
Bleeding from other sites (OV&GV) 8 (53.33%) 9 (81.82)
Treatment Conservative treatment 6 (40%) 3 (27.27%)
Band ligation 6 (40%) 6 (54.55%)
Cyanoacrylate injection 3 (20%) 2 (18.18)
  1. OV oesophageal varices, GV gastric varices